Central Unit Team
senior study-coordinator and team-manager, joined EPIMED in the year 2002 after having gathered 6 years of experience in home-care AIDS-nursing and counselling. She is responsible for the general workflow management in the study conduct, for the adherence to the EPIMED standard operating procedures, for quality control and for instructing new team members. She is the contact person for the sponsors and for the colleagues in the peripheral units.
Dr. Christina Engelhard,
investigator, joined the EPIMED-team in January 2019. Before she worked as an assistant physician at Helios Klinikum Berlin Buch in the fields of onco-hematology and tumor-immunology, transplantation of stem cells and at the intensive care unit. In close cooperation with the principal investigator Dr. Keikawus Arastéh she reviews new study protocols and controls source data. Furthermore, she is the medical contact person of the private practitioners and sponsors and CROs. She conducts informed consent process with patients, sees patients for screening visits and evaluates laboratory reports and SUA-reports.
MD,back-up to the investigator, joined EPIMED in 2004. Besides working as physician in the department of Internal Medicine / Infectious diseases of Vivantes Auguste-Viktoria-Klinikum he has conducted and attended various clinical studies intra- and extra- company.
study-coordinator, joined the EPIMED team in June 2016. Priorly she worked as a study-assistant at Charité Research Organisation in Berlin and the AIDS-Hilfe in Essen. She is a state approved nurse and degreed in Health Communication. She is responsible for the visit planning for several studies, for creating of worksheets, for the shipment logistic of laboratory samples and study drugs, for visit documentation as well as recording and maintaining the study data.
Dr. rer. nat. Susan-Beatrice Franz
is as a study-coordinator part of our team since September 2017. After graduating in biology she became a state approved nurse an latest worked as a study-nurse in the Charité – urological unit. She is responsible for the visit planning for several studies, for creating of worksheets, for the shipment logistic of laboratory samples and study drugs, for visit documentation as well as recording and maintaining the study data.
is in charge of finance and legal at EPIMED since November 2002. He is responsible for the administration of the company as well as for the budget planning of the trials. He is reviewing the offers of the sponsors and he is in charge for the approval records of the ethic advisory boards. He is controlling the company’s data-protection. Additionally he coordinates the public relations and serves as webmaster of www.epimed.org.
MD, is since 1999 Chief Executive Officer of EPIMED GmbH. As HIV specialist in private practice in Berlin-Charlottenburg he has been involved in the EPIMED studies from the very beginning. His executive functions include the review of study offers in regard to feasibility and tolerability as well as leading of the regular study meetings of the EPIMED investigators.
Priv. Doz. Dr. Keikawus Arastéh,
MD, principal investigator, is together with Dietmar Schranz one of the two Chief Executive Officers of EPIMED GmbH with focus on study acquisition. As principal investigator he bears the responsibility over all trials at EPIMED. Since 1991 he is conducting studies in the field of HIV/AIDS as well as in adjacent indications. He has published in numerous journals and he is a co-author of the German-Austrian guidelines to antiretroviral treatment of the HIV-Infection. Keikawus Arastéh is also the Director of the department of Internal Medicine, Infectious diseases (DGI) and gastroenterology of the Vivantes Auguste-Viktoria-Klinikum in Berlin.